Delayed kidney graft function: From mechanism to translation

Kidney International

Volumn 86, Issue 2, 2014, Pages 251-258

  Schröppel, Bernd ^a   Legendre, Christophe ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

acute kidney injury; delayed graft function; ischemia reperfusion; kidney transplantation; transplant outcomes

Indexed keywords

INFLAMMASOME; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ACUTE KIDNEY FAILURE; ADAPTIVE IMMUNITY; APOPTOSIS; AUTOPHAGY; BRAIN DEATH; CELL DEATH; CELL HOMING; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL TRIAL (TOPIC); COMPLEMENT SYSTEM; DELAYED GRAFT FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; GRAFT SURVIVAL; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTERVENTION STUDY; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY ISCHEMIA; KIDNEY NECROSIS; LENGTH OF STAY; NECROPTOSIS; NONHUMAN; ORGAN DONOR; PREDICTION; PREVENTION AND CONTROL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; RISK ASSESSMENT; RISK FACTOR; ACUTE KIDNEY INJURY; ADVERSE EFFECTS; ANIMAL; KIDNEY TRANSPLANTATION; PATHOLOGY; TRANSLATIONAL RESEARCH;

ACUTE KIDNEY INJURY; ADAPTIVE IMMUNITY; ANIMALS; CELL DEATH; CLINICAL TRIALS AS TOPIC; DELAYED GRAFT FUNCTION; HUMANS; IMMUNITY, INNATE; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; RISK FACTORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84905494579     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.18     Document Type: Short Survey

References (50)

1. Yarlagadda SG, Coca SG, Formica RN Jr et al. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009; 24: 1039-1047.
2. Cheung KP, Kasimsetty SG, McKay DB. Innate immunity in donor procurement. Curr Opin Organ Transplant 2013; 18: 154-160.
3. Cavaille-Coll M, Bala S, Velidedeoglu E et al. Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation. Am J Transplant 2013; 13: 1134-1148.
4. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391-1401.
5. Molitoris BA, Dagher PC, Sandoval RM et al. siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 2009; 20: 1754-1764.
6. Lau A, Wang S, Jiang J et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant 2013; 13: 2805-2818.
7. Huber TB, Edelstein CL, Hartleben B et al. Emerging role of autophagy in kidney function, diseases and aging. Autophagy 2012; 8: 1009-1031.
8. Li L, Wang ZV, Hill JA et al. New autophagy reporter mice reveal dynamics of proximal tubular autophagy. J Am Soc Nephrol 2013 (e-pub ahead of print).
9. Lieberthal W, Fuhro R, Andry C et al. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 2006; 82: 17-22.
10. Jiang M, Wei Q, Dong G et al. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012; 82: 1271-1283.
11. Liu S, Hartleben B, Kretz O et al. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy 2012; 8: 826-837.
12. Leventhal JS, Schroppel B. Toll-like receptors in transplantation: sensing and reacting to injury. kidney Int 2012; 81: 826-832.
13. Li J, Gong Q, Zhong S et al. Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant 2011; 26: 469-478.
14. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann Rev Immunol 2011; 29: 139-162.
15. Kruger B, Krick S, Dhillon N et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci USA 2009; 106: 3390-3395.
16. Rusai K, Sollinger D, Baumann M et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol 2010; 25: 853-860.
17. Shigeoka AA, Mueller JL, Kambo A et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 2010; 185: 6277-6285.
18. Iyer SS, Pulskens WP, Sadler JJ et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 2009; 106: 20388-20393.
19. McCullough JW, Renner B, Thurman JM. The role of the complement system in acute kidney injury. Seminars Nephrol 2013; 33: 543-556.
20. Damman J, Daha MR, van Son WJ et al. Crosstalk between complement and Toll-like receptor activation in relation to donor brain death and renal ischemia-reperfusion injury. Am J Transplant 2011; 11: 660-669.
21. Yamada K, Miwa T, Liu J et al. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J Immunol 2004; 172: 3869-3875.
22. Peng Q, Li K, Smyth LA et al. C3a and C5a promote renal ischemiareperfusion injury. J Am Soc Nephrol 2012; 23: 1474-1485.
23. Naesens M, Li L, Ying L et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009; 20: 1839-1851.
24. van Werkhoven MB, Damman J, van Dijk MC et al. Complement mediated renal inflammation induced by donor brain death: role of renal C5a-C5aR interaction. Am J Transplant 2013; 13: 875-882.
25. Damman J, Seelen MA, Moers C et al. Systemic complement activation in deceased donors is associated with acute rejection after renal transplantation in the recipient. Transplantation 2011; 92: 163-169.
26. Day YJ, Huang L, Ye H et al. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: the role of CD4+ T cells and IFN-gamma. J Immunol 2006; 176: 3108-3114.
27. Shen X, Wang Y, Gao F et al. CD4 T cells promote tissue inflammation via CD40 signaling without de novo activation in a murine model of liver ischemia/reperfusion injury. Hepatology 2009; 50: 1537-1546.
28. Kinsey GR, Huang L, Jaworska K et al. Autocrine adenosine signaling promotes regulatory T cell-mediated renal protection. J Am Soc Nephrol 2012; 23: 1528-1537.
29. Gaber AO, Mulgaonkar S, Kahan BD et al. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebocontrolled, multi-center Phase IIa study. Clin Transplant 2011; 25: 523-533.
30. Matignon M, Desvaux D, Noel LH et al. Arteriolar hyalinization predicts delayed graft function in deceased donor renal transplantation. Transplantation 2008; 86: 1002-1005.
31. O'Callaghan JM, Knight SR, Morgan RD et al. Preservation solutions for static cold storage of kidney allografts: a systematic review and metaanalysis. Am J Transplant 2012; 12: 896-906.
32. O'Callaghan JM, Morgan RD, Knight SR et al. Systematic review and metaanalysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes. Br J Surg 2013; 100: 991-1001.
33. Doshi MD, Garg N, Reese PP et al. Recipient risk factors associated with delayed graft function: a paired kidney analysis. Transplantation 2011; 91: 666-671.
34. Schnitzler MA, Gheorghian A, Axelrod D et al. The cost implications of first anniversary renal function after living, standard criteria deceased and expanded criteria deceased donor kidney transplantation. J Med Econ 2013; 16: 75-84.
35. Kayler LK, Magliocca J, Zendejas I et al. Impact of cold ischemia time on graft survival among ECD transplant recipients: a paired kidney analysis. Am J Transplant 2011; 11: 2647-2656.
36. Kayler LK, Srinivas TR, Schold JD. Influence of CIT-induced DGF on kidney transplant outcomes. Am J Transplant 2011; 11: 2657-2664.
37. Weber M, Dindo D, Demartines N et al. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002; 347: 248-255.
38. Kamar N, Garrigue V, Karras A et al. Impact of early or delayed cyclosporine on delayed graft function in renal transplant recipients: a randomized, multicenter study. Am J Transplant 2006; 6: 1042-1048.
39. Vincenti F, Charpentier B, Vanrenterghem Y et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10: 535-546.
40. Durrbach A, Pestana JM, Pearson T et al. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant 2010; 10: 547-557.
41. Irish WD, Ilsley JN, Schnitzler MA et al. A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant 2010; 10: 2279-2286.
42. Schroppel B, Kruger B, Walsh L et al. Tubular expression of KIM-1 does not predict delayed function after transplantation. J Am Soc Nephrol 2010; 21: 536-542.
43. Mengel M, Chang J, Kayser D et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2011; 11: 708-718.
44. Akkina SK, Connaire JJ, Israni AK et al. Similar outcomes with different rates of delayed graft function may reflect center practice, not center performance. Am J Transplant 2009; 9: 1460-1466.
45. Schnuelle P, Gottmann U, Hoeger S et al. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. J Am Med Assoc 2009; 302: 1067-1075.
46. Moers C, Smits JM, Maathuis MH et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
47. Sureshkumar KK, Hussain SM, Ko TY et al. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial. Clin J Am Soc Nephrol 2012; 7: 1498-1506.
48. Martinez F, Kamar N, Pallet N et al. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant 2010; 10: 1695-1700.
49. Seok J, Warren HS, Cuenca AG et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 2013; 110: 3507-3512.
50. Godwin JG, Ge X, Stephan K et al. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107: 14339-14344.